A Case Report on Kawasaki Disease
Kawasaki disease is a vascular and self-limiting disease mainly effecting small to medium sized vessel. Mostly affecting the children of less than 5 years. Most of the patients has a genetic predisposition. Genetically susceptible individuals exposed to infectious agents/ environmental trigger may develop Kawasaki disease. Clinical presentations are fever, polymorphous rashes along the trunk, strawberry tongue, swollen lymph nodes around neck. Skin of palms and soles can be swollen and red. Lips are cracked, red and dry. A 7 year old male patient was brought to emergency department with Scarlett fever, dry lips, Thickening of palmar skin, Itching. Patient was shifted to pediatrics department and was provided with adequate treatment.
Keywords: Kawasaki disease, Genetically susceptible, Strawberry tongue, polymorphous rashes.
2. Nakamura Y. Kawasaki disease: epidemiology and the lessons from it. Int J Rheum Dis [Internet]. 2018 Jan 1 [cited 2021 May 4];21(1):16–9. https://doi.org/10.1111/1756-185X.13211 Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/1756-185X.13211
3. Son MB, Sundel RP. Kawasaki Disease. In: Textbook of Pediatric Rheumatology [Internet]. Elsevier; 2016 [cited 2021 May 4]. p. 467-483.e6. https://doi.org/10.1016/B978-0-323-24145-8.00035-1 Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780323241458000351
4. Onouchi Y. The genetics of Kawasaki disease. Int J Rheum Dis. 2018 Jan 1;21(1):26–30 https://doi.org/10.1111/1756-185X.13218.
5. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) [Internet]. Vol. 47, Pediatrics International. John Wiley & Sons, Ltd; 2005 [cited 2021 May 4]. p. 232–4. https://doi.org/10.1111/j.1442-200x.2005.02033.x Available from: https://www.onlinelibrary.wiley.com/doi/full/10.1111/j.1442-200x.2005.02033.x
6. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Vol. 110, Circulation. 2004. p. 2747–71https://doi.org/10.1161/01.CIR.0000145143.19711.78.
7. Dallaire F, Fortier-Morissette Z, Blais S, Dhanrajani A, Basodan D, Renaud C, et al. Aspirin dose and prevention of coronary abnormalities in Kawasaki disease. Pediatrics [Internet]. 2017 Jun 1 [cited 2021 May 4];139(6):20170098 https://doi.org/10.1542/peds.2017-0098. Available from: www.aappublications.org/news
8. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017 Apr 25;135(17):e927–99 https://doi.org/10.1161/CIR.0000000000000484.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).